Rating History for Enliven Therapeutics (ELVN) by JPMorgan

More Stocks Rated by JPMorgan | Latest Ratings for ELVN
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
10/1/2026 Priyanka Grover New Coverage Overweight
(N/A)		 75.00
(N/A)		 46.51
(37.32)		 -19.76% Details